Green Thumb Industries (OTCMKTS:GTBIF) Upgraded to “Strong-Buy” at Roth Capital

Roth Capital upgraded shares of Green Thumb Industries (OTCMKTS:GTBIF) to a strong-buy rating in a research report report published on Sunday,Zacks.com reports. Roth Capital also issued estimates for Green Thumb Industries’ Q4 2024 earnings at $0.07 EPS, FY2024 earnings at $0.32 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.08 EPS and FY2025 earnings at $0.30 EPS.

Several other brokerages also recently weighed in on GTBIF. Craig Hallum raised shares of Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th. Ventum Cap Mkts raised shares of Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Three equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Strong Buy” and a consensus target price of $16.50.

Green Thumb Industries Price Performance

OTCMKTS:GTBIF opened at $9.70 on Friday. The firm has a market capitalization of $2.05 billion, a price-to-earnings ratio of 35.93 and a beta of 1.40. The company’s 50-day moving average is $10.24 and its two-hundred day moving average is $11.08. Green Thumb Industries has a 1-year low of $7.50 and a 1-year high of $16.33.

Green Thumb Industries (OTCMKTS:GTBIF) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. The company had revenue of $286.87 million during the quarter, compared to analyst estimates of $283.96 million. As a group, equities analysts anticipate that Green Thumb Industries will post 0.32 earnings per share for the current fiscal year.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.